Vasopressin cell antibodies and central diabetes insipidus in a patient with systemic lupus erythematosus and dermatomyositis

Journal of Rheumatology

Volumn 31, Issue 6, 2004, Pages 1218-1221

  Kajiyama, Hiroshi ^a   Terai, Chihiro ^a   De Bellis, Annamaria ^b   Bizzarro, Antonio ^b   Bellastella, Antonio ^b   Ohta, Shuji ^a   Okamoto, Hiroshi ^a   Uesato, Masashi ^a   Hara, Masako ^a   Kamatani, Naoyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Central diabetes insipidus; Systemic lupus erythematosus; Vasopressin cell antibodies

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL ANTIBODY; CYCLOPHOSPHAMIDE; HORMONE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; STEROID; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN CELL ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CENTRAL DIABETES INSIPIDUS; DERMATOMYOSITIS; DIABETES INSIPIDUS; FEMALE; HORMONE SUBSTITUTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NEUROGENIC DIABETES INSIPIDUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; VASOPRESSIN RELEASE;

ADULT; CYCLOPHOSPHAMIDE; DERMATOMYOSITIS; DIABETES INSIPIDUS, NEUROGENIC; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; VASOPRESSINS;

EID: 2642561878     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Arafah BM, Nasrallah MP. Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer 2001;8:297-305.
2. Hensen J, Seufferlein T, Oelkers W. Atherosclerosis, aortic stenosis and sudden onset central diabetes insipidus. Exp Clin Endocrinol Diabetes 1997;105:227-33.
3. Schucart WA, Jackson I. Management of diabetes insipidus in neurosurgical patients. J Neurosurg 1976;44:65-7.
4. Yuan XQ, Wade CE. Neuroendocrine abnormalities in patients with traumatic brain injury. Front Neuroendocrinol 1991;12:209-30.
5. Imai H, Okuyama S, Komatsuda A, Wakui H, Miura AB. Central diabetes insipidus due to lymphocytic infundibuloneurohypophysitis. Am J Med 2000;109:497-9.
6. De Bellis A, Colao A, Bizzarro A, et al. Longitudinal study of vasopressin-cell antibodies and of hypothalamic-pituitary region on magnetic resonance imaging in patients with autoimmune and idiopathic complete central diabetes insipidus. J Clin Endocrinol Metab 2002;87:3825-9.
7. Scherbaum WA, Bottazzo GF. Autoantibodies to vasopressin cells in idiopathic diabetes insipidus: evidence for an autoimmune variant. Lancet 1983;1:897-901.
8. De Bellis A, Bizzarro A, Amoresano Paglionico V, et al. Detection of vasopressin cell antibodies in some patients with autoimmune endocrine diseases without overt diabetes insipidus. Clin Endocrinol (Oxf) 1994;40:173-7.
9. Tekin N, Kural N, Kocak AK, Kose S. Diabetes insipidus in a pediatric, patient with systemic lupus erythematosus. A case report. Turk J Pediatr 1997;39:281-4.
10. Sanchez-Roman J, Castillo-Palma MJ, Ocana Medina C, Villamil-Fernandez F, Wichmann I. Neurogenic diabetes insipidus in patients with systemic lupus erythematosus. Ann Rheum Dis 1998;57:261-2.
11. De Bellis A, Colao A, Di Salle F, et al. A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus. J Clin Endocrinol Metab 1999;84:3047-51.